- Publication venue
- Publication date
- 01/01/2013
- Field of study
- Publication venue
- Publication date
- 01/01/2013
- Field of study
- Publication venue
- Publication date
- 01/01/2013
- Field of study
- Publication venue
- Publication date
- 01/01/2013
- Field of study
- Publication venue
- 'Springer Science and Business Media LLC'
- Publication date
- 01/01/2018
- Field of study
- Publication venue
- 'Springer Science and Business Media LLC'
- Publication date
- 08/07/2019
- Field of study
Direct head-to-head studies comparing the long-term outcomes of infliximab (IFX) to adalimumab (ADA) in Crohn's disease (CD) are sparse